Immune to Cancer: The CRI Blog
-
Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…
-
Gynecologic Cancer Awareness Month: 2021 Immunotherapy Research Updates
This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI…
-
Christine Sable’s Immunotherapy Story
Ovarian Cancer | Diagnosed 2003 Christine’s Story At age 44, Christine Sable had few worries about her cancer… -
Dr. Kunle Odunsi Answers Questions About Ovarian Cancer and Immunotherapy From the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi of Roswell Park Comprehensive Cancer Center answers questions about ovarian cancer and immunotherapy from…
-
Ovarian Cancer and Immunotherapy Breakout Session at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.
-
Gynecologic Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Gynecologic Cancer Awareness Month, we look at new FDA approvals, new research, and how…
-
How Immunotherapy is Making an Impact in Gynecologic Cancers
For Gynecologic Cancer Awareness Month, CRI spoke with Dr. Kunle Odunsi about immunotherapies for ovarian, cervical, and…
-
Ovarian Cancer Awareness Month: 2019 Immunotherapy Research Update
For Ovarian Cancer Awareness Month, we round up the latest news and research from the people changing…
-
How Immunotherapy Is Making an Impact in Ovarian Cancer
We spoke with Dmitriy Zamarin, MD, PhD, about the current treatment landscape for patients with ovarian cancer,…